Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 5 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
RemyDerm from Leuven, company number BE0787206864, closed financial year 2025 with a result of € 27,348 after tax. For that financial year RemyDerm recorded a gross margin of € 132,266 and equity of € -198,284. Compared with financial year 2024, the result moved from € -177,452 to € 27,348. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ -198,284
▲ € 27,348 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 27,348
▲ still € 177,452 loss in 2024
Profit after tax over the fiscal year.
€ 11,829
▼ 91% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -364,604.
Debts at end 2025
€ 1.4 million
▲ 5% vs 2024
€ 67,540 is repaid this year. At this pace the long-term loan is gone in ≈ 21 years.
€ 45
▼ € 128,001 vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -20,917 | € -11,717 | € -1,945 | € 132,266 | ▲ € 134,211 |
| Profit after taxes | € -117,593 | € -96,907 | € -177,452 | € 27,348 | ▲ € 204,800 |
| Equity | € 48,727 | € -48,180 | € -225,632 | € -198,284 | ▲ € 27,348 |
| Total debts | € 660,000 | € 748,799 | € 1,653,134 | € 1,588,016 | ▼ 4% |
| Cash | € 13,649 | € 20,389 | € 138,559 | € 11,829 | ▼ 91% |
| Land & buildings | € 695,078 | € 680,229 | € 665,381 | € 1,377,903 | ▲ 107% |
| Retained profit | € -117,593 | € -214,500 | € -391,952 | € -364,604 | ▲ € 27,348 |
| Bank debt | € 660,000 | € 706,299 | € 1,332,396 | € 1,395,279 | ▲ 5% |
| Balance sheet total | € 708,727 | € 700,619 | € 1,427,501 | € 1,389,732 | ▼ 3% |
Key figures of RemyDerm, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to RemyDerm?
What happened at RemyDerm in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 27,348. Source: NBB ↗
- Liesbet Maria A De Wachter became a director. NBB
- Ruth Luyckx became a director. NBB
- New establishment in Leuven. KBO
- Sofie Reinhilde Curvers became a director. NBB
- Sara Gabrielle Vansina became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 117,593 loss in 2022 to € 27,348 profit in 2025.
Best year ever: 2025, with € 27,348 profit.
Management
Behind RemyDerm are Ruth Luyckx, Sofie Reinhilde Curvers, Sara Gabrielle Vansina and Liesbet Maria A De Wachter. Ruth Luyckx is also behind DR.RUTH LUYCKX, dermatologe. Sara Gabrielle Vansina is also behind Dr. Sara Vansina, Dermatologie.
Directors
According to the 2025 annual accounts
since 2023
Sofie Reinhilde Curvers
Director
since 2022
since 2022
Liesbet Maria A De Wachter
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Baron August de Becker-Remyplein 47/49
3010 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0787.206.864
- VAT number
- BE 0787.206.864
- Registered office
- Baron August de Becker-Remyplein 47/49, 3010 Leuven
- Names & denominations
- RemyDerm
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 June 2022
- Peppol
- Active · Active since 2 Sept 2025